These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37092108)

  • 1. A preliminary study to evaluate the impact of pharmaceutical care services on clinical outcome and medication adherence in type 2 diabetes mellitus patients from Ethiopian perspective.
    Billoro BB; Abdi AM; Abero WA; Fite AB; Basgut B
    Afr Health Sci; 2022 Dec; 22(4):104-118. PubMed ID: 37092108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    Negash Z; Berha AB; Shibeshi W; Ahmed A; Woldu MA; Engidawork E
    PLoS One; 2021; 16(6):e0251709. PubMed ID: 34077431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S; Morgado M; Falcão A; Alves G
    J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan.
    Javaid Z; Imtiaz U; Khalid I; Saeed H; Khan RQ; Islam M; Saleem Z; Sohail MF; Danish Z; Batool F; Anwer N
    BMC Health Serv Res; 2019 Jun; 19(1):409. PubMed ID: 31234840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.
    Skinner JS; Poe B; Hopper R; Boyer A; Wilkins CH
    Diabetes Educ; 2015 Aug; 41(4):459-65. PubMed ID: 26009557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
    Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
    J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service.
    McCord AD
    Pharmacotherapy; 2006 Feb; 26(2):248-53. PubMed ID: 16466329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
    Morgado M; Rolo S; Castelo-Branco M
    Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK; Grace KA; Taylor AJ
    JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia.
    Besemah NA; Sartika RAD; Sauriasari R
    J Res Pharm Pract; 2020; 9(4):186-195. PubMed ID: 33912501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
    Wishah RA; Al-Khawaldeh OA; Albsoul AM
    Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-Analysis.
    Khan YH; Alzarea AI; Alotaibi NH; Alatawi AD; Khokhar A; Alanazi AS; Butt MH; Alshehri AA; Alshehri S; Alatawi Y; Mallhi TH
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.
    Östbring MJ; Eriksson T; Petersson G; Hellström L
    BMC Cardiovasc Disord; 2021 Aug; 21(1):367. PubMed ID: 34334142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.